Latest Paclitaxel Stories
UPPSALA, Sweden, April 20, 2015 /PRNewswire/ -- Oasmia Pharmaceutical AB ("Oasmia") announced today that its lead cancer product Paclical received market authorization
-- Animal model highly representative of late-stage ovarian cancer in women PHILADEPHIA, April 20, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT;
Data to support ongoing work with Halozyme's investigational new drug PEGPH20 in combination with immuno-oncology agents SAN DIEGO, April 20, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.
SAN DIEGO, April 18, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Recent FDA meeting allows for potential marketing application based on progression free survival in pivotal Phase 3 pancreatic cancer study SAN DIEGO, April 8, 2015 /PRNewswire/ -- Halozyme
LONDON, April 8, 2015 /PRNewswire/ -- SummaryGBI Research, has released the pharma report -"Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline
BUFFALO, N.Y., March 9, 2015 /PRNewswire/ -- Kinex Pharmaceuticals and Hanmi Pharmaceutical Co., Ltd.
EWING, N.J., March 2, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
HONG KONG, Feb.
CALGARY, Feb. 11, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).